Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ science, today announced the formal launch of the first drug candidate of NAD Pharmaceuticals Corp., its wholly owned subsidiary ...

Repairing the Reflecting Pool, wrapping up DOGE and fixing potholes in D.C. were all on the president's list to complete in ...

Opus Genetics, Inc. (Nasdaq: IRD) (the "Company”, "Opus Genetics” or "Opus”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients ...

Opus Genetics, Inc. (Nasdaq: IRD) (the "Company", "Opus Genetics" or "Opus"), a clinical-stage biopharmaceutical company developing gene ...

Opus Genetics, Inc. (Nasdaq: IRD) (the "Company” or "Opus Genetics”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with ...

Nebraska businesses providing applied behavioral analysis therapy — known as ABA — are now facing additional requirements from the state.

Vanta reports four risk treatment strategies-mitigate, accept, transfer, and avoid-to effectively manage threats, enhancing ...

Trump’s plans for dismantling the Education Department are sparking concerns that the federal government will fall short in ...

Internal documents contradict statements from USDA leaders, who repeatedly said they did not anticipate relocations would ...

July-August 2026 The July issue of Supply Chain Management Review explores how organizations are preparing for the future ...

Locally-based Apptronik debuted its Apollo 2 humanoid robot to be used at the company's newly opened North Austin training ...

Two universities announced plans to cut more than 100 employees last month, while multiple others announced their own ...